Journey Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	27.44	32	49.08	8.25	4.8
Cash & Cash Equivalents	27.44	32	49.08	8.25	4.8
Cash Growth	-14.26%	-34.80%	495.21%	71.76%	-
Receivables	15.22	28.21	23.11	23.93	18.96
Inventory	10.21	14.16	9.86	1.4	0.86
Other Current Assets	3.59	3.31	2.44	1.66	0.66
Total Current Assets	56.46	77.68	84.49	35.24	25.27
Property, Plant & Equipment	0.1	0.19	0.09	0.18	0.09
Goodwill and Intangibles	20.29	27.2	12.55	15.03	7.38
Other Long-Term Assets	0.01	0.1	0.15	1.46	1.13
Total Long-Term Assets	20.39	27.48	12.79	16.66	8.59
Total Assets	76.85	105.16	97.28	51.91	33.86
Accounts Payable	18.34	36.98	23.45	1.96	2.11
Deferred Revenue	0	4.99	0	0	0
Current Debt	3.1	5.28	5.42	4.61	0.08
Other Current Liabilities	20.43	19.58	22.74	21.5	18.71
Total Current Liabilities	41.87	66.83	51.61	28.06	20.9
Long-Term Debt	14.63	21.35	3.63	13.45	10.21
Other Long-Term Liabilities	0	0	0	0.1	0
Total Long-Term Liabilities	14.63	21.35	3.63	13.55	10.21
Total Liabilities	56.5	88.18	55.24	41.61	31.11
Total Debt	17.73	26.62	9.05	18.06	10.29
Debt Growth	-33.40%	194.25%	-49.91%	75.47%	-
Retained Earnings	-72.36	-68.5	-38.87	5.12	-0.16
Shareholders' Equity	20.35	16.98	42.04	10.29	2.75
Net Cash / Debt	9.71	5.38	40.03	-9.82	-5.49
Net Cash / Debt Growth	80.40%	-86.56%	-	-	-
Net Cash Per Share	0.53	0.31	3.93	-0.91	-0.55
Working Capital	14.59	10.85	32.88	7.18	4.37
Book Value Per Share	1.12	0.97	4.13	1.13	0.30

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).